SAN DIEGO, April 10, 2024 (GLOBE NEWSWIRE) -- Shareholder rights law firm Robbins LLP informs investors it is investigating the acquisition of Catalent, Inc. (NYSE:CTLT) by Novo Holdings, a holding and investment company that is responsible for managing the assets and wealth of the Novo Nordisk Foundation. Under the terms of the agreement, Catalent stockholders will receive $63.50 in cash for each share of Catalent common stock owned.
If you own shares of Catalent, Inc. click here.
Is the Proposed Acquisition Best for Catalent, Inc. (CTLT) and its Shareholders?
On February 2, 2024, the companies announced a merger agreement under which Novo Holdings ...